We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
-14.59%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$70.1B
AUM Growth
-$16.1B
(-19%)
Cap. Flow
-$2.27B
Cap. Flow
% of AUM
-3.24%
Top 10 Holdings %
Top 10 Hldgs %
16.75%
Holding
1,919
New
109
Increased
944
Reduced
712
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$803M |
| 2 |
Alibaba
BABA
|
+$375M |
| 3 |
Nektar Therapeutics
NKTR
|
+$213M |
| 4 |
Meta Platforms (Facebook)
META
|
+$209M |
| 5 |
SLB Ltd
SLB
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$1.01B |
| 2 |
New Oriental
EDU
|
+$317M |
| 3 |
Comcast
CMCSA
|
+$241M |
| 4 |
Intercontinental Exchange
ICE
|
+$238M |
| 5 |
DaVita
DVA
|
+$203M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.28% |
| 2 | Technology | 14.55% |
| 3 | Healthcare | 13.72% |
| 4 | Energy | 13.45% |
| 5 | Financials | 13.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Xeris Biopharma Holdings
XERS
$1.42B
| $17M | 0.02% |
1,000,000
| – | – |
|
552
WEX
WEX
$6.17B
| $16.9M | 0.02% |
120,592
-5,499
| -4% | -$905K |
|
553
Roku
ROKU
$21.2B
| $16.8M | 0.02% |
547,480
+103,980
| +23% | +$4.9M |
|
554
Simply Good Foods
SMPL
$943M
| $16.7M | 0.02% |
+885,150
| New | +$16.7M |
|
|
WMGI
555
DELISTED
Wright Medical Group Inc
WMGI
| $16.7M | 0.02% |
614,378
+24,023
| +4% | +$664K |
|
|
ONCE
556
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $16.7M | 0.02% |
425,690
-760
| -0.2% | -$33K |
|
|
TCF
557
DELISTED
TCF Financial Corporation Common Stock
TCF
| $16.6M | 0.02% |
454,485
+17,884
| +4% | +$817K |
|
558
Henry Schein
HSIC
$9.64B
| $16.5M | 0.02% |
268,459
+250,006
| +1,355% | +$16.5M |
|
|
EPAY
559
DELISTED
Bottomline Technologies Inc
EPAY
| $16.5M | 0.02% |
343,334
+142,365
| +71% | +$8.23M |
|
560
Booz Allen Hamilton
BAH
$8.59B
| $16.3M | 0.02% |
361,653
+193,090
| +115% | +$9.48M |
|
561
Enpro
NPO
$6.95B
| $16.2M | 0.02% |
268,970
+10,866
| +4% | +$720K |
|
562
McKesson
MCK
$99.5B
| $16M | 0.02% |
144,991
+3,194
| +2% | +$398K |
|
563
DexCom
DXCM
$28.3B
| $16M | 0.02% |
532,836
-2,780,068
| -84% | -$88.2M |
|
564
Tractor Supply
TSCO
$16.7B
| $15.8M | 0.02% |
944,270
+901,030
| +2,084% | +$16.2M |
|
565
OceanFirst Financial
OCFC
$1.7B
| $15.7M | 0.02% |
698,809
+33,379
| +5% | +$836K |
|
566
ASML
ASML
$636B
| $15.6M | 0.02% |
100,395
-51,555
| -34% | -$8.74M |
|
567
WD-40
WDFC
$3.13B
| $15.6M | 0.02% |
85,086
+83,415
| +4,992% | +$14.1M |
|
568
Jazz Pharmaceuticals
JAZZ
$16B
| $15.5M | 0.02% |
125,368
+14,690
| +13% | +$2.18M |
|
569
Addus HomeCare
ADUS
$2.16B
| $15.5M | 0.02% |
228,828
+13,825
| +6% | +$945K |
|
570
Dycom Industries
DY
$12.7B
| $15.5M | 0.02% |
286,311
+15,912
| +6% | +$1.07M |
|
571
Bio-Rad Laboratories Class A
BIO
$8.47B
| $15.4M | 0.02% |
66,426
-12,843
| -16% | -$3.45M |
|
|
SUM
572
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $15.4M | 0.02% |
1,264,591
+153,759
| +14% | +$2.13M |
|
573
Zebra Technologies
ZBRA
$12.6B
| $15.4M | 0.02% |
96,412
-31,618
| -25% | -$5.26M |
|
|
HES
574
DELISTED
Hess
HES
| $15.3M | 0.02% |
377,916
-133,470
| -26% | -$7.61M |
|
575
TE Connectivity
TEL
$60.2B
| $15.3M | 0.02% |
202,218
-14,452
| -7% | -$1.11M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2018 Portfolio in Review
As of Q4 2018, OppenheimerFunds held 1,919 positions worth $70.1B, down 19% from $86.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds withdrew a net $2.27B in Q4 2018, closing 131 positions and reducing 712 holdings. Its most notable exit was Energy Transfer Partners, L.P., an estimated $1.01B position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
Against the trend, OppenheimerFunds opened a new position in Caesars Entertainment Corporation worth $68.1M.
- OppenheimerFunds's largest Q4 2018 buy was Caesars Entertainment Corporation: 10,035,079 shares worth $68.1M.
- OppenheimerFunds added most to Energy Transfer Partners in Q4 2018, an estimated $803M increase.
- OppenheimerFunds's biggest Q4 2018 reduction was New Oriental, cutting an estimated $317M.
- OppenheimerFunds fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.01B.
- OppenheimerFunds's ten largest holdings make up 17% of its $70.1B portfolio in Q4 2018.
- OppenheimerFunds opened 109 new positions and closed 131 in Q4 2018.
- OppenheimerFunds's portfolio value fell 19% quarter-over-quarter to $70.1B.
Based on OppenheimerFunds's 13F filing for Q4 2018, filed 11 Feb 2019.